Epcoritamab featured in multiple data disclosures, including four oral presentations Results presented from the phase 1b/2 EPCORE NHL-2 trial of epcoritamab combined with standard salvage
BEIJING, Dec. 8 (Xinhua) China has reported progress in biodiversity as a result of enhanced legislation and policy protection. A total of 90 percent of the